Abstract

Studies show that a decrease in protein kinase CK2 (CK2) activity is associated with cellular senescence. However, the role of CK2 in organism aging is still poorly understood. Here, we investigated whether protein kinase CK2 (CK2) modulated longevity in Caenorhabditis elegans. CK2 activity decreased with advancing age in the worms. Knockdown of kin-10 (the ortholog of CK2β) led to a short lifespan phenotype and induced age-related biomarkers, including retardation of locomotion, decreased pharyngeal pumping rate, increased lipofuscin accumulation, and reduced resistance to heat and oxidative stress. The long lifespan of age-1 and akt-1 mutants was significantly suppressed by kin-10 RNAi, suggesting that CK2 acts downstream of AGE-1 and AKT-1. Kin-10 knockdown did not further shorten the short lifespan of daf-16 mutant worms but either decreased or increased the transcriptional activity of DAF-16 depending on the promoters of the target genes, indicating that CK2 is an upstream regulator of DAF-16 in C. elegans. Kin-10 knockdown increased production of reactive oxygen species (ROS) in the worms. Finally, the ROS scavenger N-acetyl-L-cysteine significantly counteracts the lifespan shortening and lipofuscin accumulation induced by kin-10 knockdown. Therefore, the present results suggest that age-dependent CK2 downregulation reduces longevity by associating with both ROS generation and the AGE-1-AKT-1-DAF-16 pathway in C. elegans.

Highlights

  • The nematode Caenorhabditis elegans has been widely used as a model for exploring the mechanisms underlying aging

  • To investigate whether CK2 regulates the longevity of C. elegans, we compared the lifespan of worms treated with kin-10 RNAi with that of worms treated with empty vector control (L4440) RNAi

  • We examined whether CK2 modulated longevity in C. elegans

Read more

Summary

Introduction

The nematode Caenorhabditis elegans has been widely used as a model for exploring the mechanisms underlying aging. A crucial pathway influencing C. elegans aging is the insulin/insulin-like growth factor (IGF)-1 signaling (IIS) pathway. Key components of the IIS pathway are daf-2/IGF receptor (IGFR), age-1/ phosphoinositide 3-kinase (PI3K), and akt-1/AKT-1/2 [14]. The transcription factor DAF-16/FoxO lies downstream of the IIS pathway [5, 6]. DAF-2/IGFR activation leads to the activation of AGE-1/PI3K, which in turn activates. AKT, resulting in phosphorylation and cytoplasmic sequestration of DAF-16/FoxO [7]. Inhibition of DAF-2/ IGFR or AGE-1/PI3K allows translocation of DAF-16/ FoxO into the nucleus, where DAF-16/FoxO activates the transcription of pro-longevity genes, including antioxidant and thermotolerant genes [8, 9]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call